{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:53:10Z","timestamp":1787755990991,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00259-020-05128-8","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T15:20:58Z","timestamp":1610119258000},"page":"2586-2598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET\/CT"],"prefix":"10.1007","volume":"48","author":[{"given":"Bei-Bei","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Song","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Feng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Jun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Nan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Qiang","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Quan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"5128_CR1","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","volume":"387","author":"MLK Chua","year":"2016","unstructured":"Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387:1012\u201324.","journal-title":"Lancet"},{"key":"5128_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394:64\u201380.","journal-title":"Lancet"},{"key":"5128_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ijrobp.2019.06.2549","volume":"105","author":"X Sun","year":"2019","unstructured":"Sun X, Liu S, Luo M, et al. The association between the development of radiation therapy, image technology, and chemotherapy, and the survival of patients with nasopharyngeal carcinoma: a cohort study from 1990 to 2012. Int J Radiat Oncol Biol Phys. 2019;105:581\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5128_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejca.2017.02.029","volume":"77","author":"X Zou","year":"2017","unstructured":"Zou X, You R, Liu H, et al. Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment. Eur J Cancer. 2017;77:117\u201326.","journal-title":"Eur J Cancer"},{"key":"5128_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.oraloncology.2014.01.004","volume":"50","author":"OS Chan","year":"2014","unstructured":"Chan OS, Ngan RK. Individualized treatment in stage IVC nasopharyngeal carcinoma. Oral Oncol. 2014;50:791\u20137.","journal-title":"Oral Oncol"},{"key":"5128_CR6","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1200\/JCO.2012.46.0816","volume":"31","author":"LQ Tang","year":"2013","unstructured":"Tang LQ, Chen QY, Fan W, et al. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography\/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2013;31:2861\u20139.","journal-title":"J Clin Oncol"},{"key":"5128_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12885-017-3630-9","volume":"17","author":"L Yang","year":"2017","unstructured":"Yang L, Xia L, Wang Y, et al. Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma. BMC Cancer. 2017;17:628.","journal-title":"BMC Cancer"},{"issue":"49","key":"5128_CR8","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ejca.2013.03.003","volume":"1990","author":"W Xia","year":"2013","unstructured":"Xia W, Zhang H, Shi J, et al. A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification. Eur J Cancer. 2013;1990(49):2152\u201360.","journal-title":"Eur J Cancer"},{"key":"5128_CR9","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1002\/cncr.30541","volume":"123","author":"J Huang","year":"2017","unstructured":"Huang J, Fogg M, Wirth L, et al. Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma. Cancer. 2017;123:2642\u201350.","journal-title":"Cancer"},{"key":"5128_CR10","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.7150\/jca.18361","volume":"8","author":"C Xu","year":"2017","unstructured":"Xu C, Zhang Y, Peng L, et al. Optimal modality for detecting distant metastasis in primary nasopharyngeal carcinoma during initial staging: a systemic review and meta-analysis of 1774 patients. J Cancer. 2017;8:1238\u201348.","journal-title":"J Cancer"},{"key":"5128_CR11","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.2967\/jnumed.107.043406","volume":"48","author":"FY Liu","year":"2007","unstructured":"Liu FY, Lin CY, Chang JT, et al. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma. J Nucl Med. 2007;48:1614\u20139.","journal-title":"J Nucl Med"},{"key":"5128_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/hed.20974","volume":"31","author":"M Chua","year":"2009","unstructured":"Chua M, Ong S, Wee J, et al. Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head Neck. 2009;31:346\u201354.","journal-title":"Head Neck"},{"key":"5128_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejrad.2017.02.002","volume":"89","author":"R YY","year":"2017","unstructured":"YY R, YC L, HB W, et al. Whole-body F-FDG PET\/CT for M staging in the patient with newly diagnosed nasopharyngeal carcinoma: who needs? Eur J Radiol. 2017;89:200\u20137.","journal-title":"Eur J Radiol"},{"key":"5128_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40880-017-0265-9","volume":"36","author":"LC H P","year":"2017","unstructured":"H P LC, LL T, et al. Significant value of F-FDG-PET\/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Chin J Cancer. 2017;36:95.","journal-title":"Chin J Cancer"},{"key":"5128_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejrad.2012.06.031","volume":"82","author":"MC Chang","year":"2013","unstructured":"Chang MC, Chen JH, Liang JA, et al. Accuracy of whole-body FDG-PET and FDG-PET\/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2013;82:366\u201373.","journal-title":"Eur J Radiol"},{"key":"5128_CR16","unstructured":"National Comprehensive Cancer Network. Head and Neck Cancers (Version 3.2019). In. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. September 16, 2019."},{"key":"5128_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejrad.2017.02.002","volume":"89","author":"YY Ren","year":"2017","unstructured":"Ren YY, Li YC, Wu HB, et al. Whole-body (18)F-FDG PET\/CT for M staging in the patient with newly diagnosed nasopharyngeal carcinoma: who needs? Eur J Radiol. 2017;89:200\u20137.","journal-title":"Eur J Radiol"},{"key":"5128_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1200\/JCO.2005.03.8760","volume":"24","author":"FY Liu","year":"2006","unstructured":"Liu FY, Chang JT, Wang HM, et al. [18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol. 2006;24:599\u2013604.","journal-title":"J Clin Oncol"},{"key":"5128_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00259-008-0918-7","volume":"36","author":"SH Ng","year":"2009","unstructured":"Ng SH, Chan SC, Yen TC, et al. Staging of untreated nasopharyngeal carcinoma with PET\/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging. 2009;36:12\u201322.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5128_CR20","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1002\/cam4.2343","volume":"8","author":"S XS","year":"2019","unstructured":"XS S, WH C, SL L, et al. Individualized concurrent chemotherapy by pretreatment plasma Epstein-Barr viral DNA in II-III stage nasopharyngeal carcinoma: a propensity score matching analysis using a large cohort. Cancer Med. 2019;8:4214\u201325.","journal-title":"Cancer Med"},{"key":"5128_CR21","first-page":"885","volume":"47","author":"D Delbeke","year":"2006","unstructured":"Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumor imaging with 18F-FDG PET\/CT 1.0. J Nucl Med. 2006;47:885\u201395.","journal-title":"J Nucl Med"},{"key":"5128_CR22","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1200\/JCO.2006.05.7349","volume":"24","author":"S Ng","year":"2006","unstructured":"Ng S, Yen T, Chang J, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol. 2006;24:4371\u20136.","journal-title":"J Clin Oncol"},{"key":"5128_CR23","unstructured":"Tang LQ, Li CF, Li J, et al. Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma. J Natl Cancer Inst. 2016:108."},{"key":"5128_CR24","first-page":"6878","volume":"60","author":"YM Lo","year":"2000","unstructured":"Lo YM, Chan AT, Chan LY, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res. 2000;60:6878\u201381.","journal-title":"Cancer Res"},{"key":"5128_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1442-2050.2007.00750.x","volume":"21","author":"S Zenda","year":"2008","unstructured":"Zenda S, Hironaka S, Boku N, et al. Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4\/M1 lymph node esophageal cancer. Dis Esophagus. 2008;21:195\u2013200.","journal-title":"Dis Esophagus"},{"key":"5128_CR26","doi-asserted-by":"publisher","first-page":"e0136033","DOI":"10.1371\/journal.pone.0136033","volume":"10","author":"S Guo","year":"2015","unstructured":"Guo S, Tang L, Chen Q, et al. Is hemoglobin level in patients with nasopharyngeal carcinoma still a significant prognostic factor in the era of intensity-modulated radiotherapy technology? PLoS One. 2015;10:e0136033.","journal-title":"PLoS One"},{"key":"5128_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"P Hsu","year":"2008","unstructured":"Hsu P, Sabatini D. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703\u20137.","journal-title":"Cell"},{"key":"5128_CR28","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.7150\/jca.32716","volume":"10","author":"G Long","year":"2019","unstructured":"Long G, Tang W, Fu X, et al. Pre-treatment serum lactate dehydrogenase predicts distant metastasis and poor survival in nasopharyngeal carcinoma. J Cancer. 2019;10:3657\u201364.","journal-title":"J Cancer"},{"key":"5128_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.7150\/jca.22190","volume":"9","author":"R Oei","year":"2018","unstructured":"Oei R, Ye L, Kong F, et al. Pre-treatment serum lactate dehydrogenase is predictive of survival in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiotherapy. J Cancer. 2018;9:54\u201363.","journal-title":"J Cancer"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-05128-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-020-05128-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-05128-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T02:08:37Z","timestamp":1624932517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-020-05128-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5128"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-05128-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"8 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}